Sunday, August 18, 2019

Bias, Corruption & Accountability

Review Finds FDA Approval of Digital Antipsychotic Misguided

The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.

Positive Antidepressant Study “Misleading” and “Erroneous”

An analysis of last year’s positive finding in The Lancet about antidepressant efficacy shows errors, obfuscations, and misrepresentations.

Getting Pharma Out of Medical Education: An Interview with Dr. Adriane Fugh-Berman

MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.

Mad Science, Psychiatric Coercion and the Therapeutic State: An Interview with Dr. David Cohen

MIA's Peter Simons interviews David Cohen, PhD, on his path to researching mental health, coercive practices, and discontinuation from psychiatric drugs.

Mobile Apps for Mental Health Lack Transparency in Data Sharing

Research illustrates privacy concerns with how mental health applications collect and share users’ data.

Fighting for the Meaning of Madness: An Interview with Dr. John Read

Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.

Study Reveals Inconsistency in ADHD Diagnostic Determinations

Researchers compare differences between research and clinical diagnoses of ADHD and explore the consistency of clinical determinations over time

Researchers Find Bias in Industry-Funded Continuing Medical Education

Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.

Researchers Fail to Replicate Evidence for “Biotypes” of Depression

A new study casts doubt on whether such biotypes for depression exist.

Antidepressant Use Linked to Longer, More Frequent Psychiatric Rehospitalization

New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.

The Impact of Regression to the Mean in Psychiatric Drug Studies

Could the statistical phenomenon of regression to the mean be responsible for the dramatic effects of placebo—as well as the supposed effectiveness of some psychiatric drugs?

Withdrawal Symptoms Routinely Confound Findings of Psychiatric Drug Studies

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

Psychiatrists View Drug-Free Programs for Psychosis as “Unscientific,” Study Finds

A new study provides an insider’s look into how psychiatrists view the establishment of drug-free programs in Norway.

No Brain Connectivity Differences Between Autism, ADHD, and “Typical Development”

Neuroscience researchers find no differences in brain connectivity between children with diagnoses of autism, ADHD, and those with no diagnoses.

Debate Ensues Over Rights-Based Approach to Mental Health

Debate ensues as scholars and policymakers discuss how to bring a rights-based approach to mental health policy.

Adderall Use Associated with Increased Risk of Psychosis

Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.

Does Active Placebo Response Explain Antidepressant Results?

A new study investigated whether participants guessing if they have an antidepressant or placebo affects response rates.

It is Time to Abandon the Candidate-Gene Approach to Depression

The candidate-gene approach to depression goes unsupported and is likely based on bad science, new research finds.

First-Person Accounts of Madness and Global Mental Health: An Interview with Dr. Gail Hornstein

Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.

Mental Health Concerns Not “Brain Disorders,” Say Researchers

The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not “brain disorders.”

How Do Clients Solicit Medication Changes With Psychiatrists?

Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.

Very Slow Tapering Best For Antidepressant Withdrawal

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

New Book Deconstructs Ideology of Cognitive Therapy

CBT forwards a hyper-rational perspective of human suffering that complements a managerialist culture of efficiency and institutionalization in the Western world.
institutional corruption

Institutional Corruption in the Cochrane Collaboration

My story is not just about the personal costs of speaking truth to power. This is a story about institutional corruption and one of the worst show trials in academia that you can imagine. I have written a book that documents the truth, backed by leaked board room recordings, private emails and testimony from concerned citizens.

Opioids May Cause Depression and Worsen Chronic Pain

“Converging lines of evidence now suggest that depression—a common comorbidity in the setting of chronic pain—may in some patients represent an unrecognized yet potentially reversible harm of opioid therapy.”

Follow Us

19,639FansLike
11,994FollowersFollow
3,180SubscribersSubscribe